Raily Aesthetic Medicine International Holdings Limited

SEHK:2135 주식 보고서

시가총액: HK$65.2m

Raily Aesthetic Medicine International Holdings 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jianliang Song

최고 경영자

CN¥933.0k

총 보상

CEO 급여 비율96.5%
CEO 임기2.9yrs
CEO 소유권n/a
경영진 평균 재임 기간3.5yrs
이사회 평균 재임 기간3.9yrs

최근 관리 업데이트

Recent updates

Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%

Oct 02
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%

Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price

Jul 22
Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price

Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive

Apr 22
Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive

Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected

Feb 07
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected

Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing

Dec 19
Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing

Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected

Aug 22
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected

Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are

Sep 17
Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are

CEO 보상 분석

Jianliang Song 의 보수는 Raily Aesthetic Medicine International Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-CN¥32m

Mar 31 2024n/an/a

-CN¥32m

Dec 31 2023CN¥933kCN¥900k

-CN¥32m

Sep 30 2023n/an/a

-CN¥26m

Jun 30 2023n/an/a

-CN¥20m

Mar 31 2023n/an/a

-CN¥18m

Dec 31 2022CN¥647kCN¥600k

-CN¥16m

Sep 30 2022n/an/a

-CN¥13m

Jun 30 2022n/an/a

-CN¥11m

Mar 31 2022n/an/a

-CN¥14m

Dec 31 2021CN¥1mCN¥1m

-CN¥18m

Sep 30 2021n/an/a

-CN¥3m

Jun 30 2021n/an/a

CN¥11m

Mar 31 2021n/an/a

CN¥8m

Dec 31 2020CN¥1mCN¥1m

CN¥4m

Sep 30 2020n/an/a

-CN¥25k

Jun 30 2020n/an/a

-CN¥4m

Mar 31 2020n/an/a

CN¥3m

Dec 31 2019CN¥2mCN¥2m

CN¥10m

보상 대 시장: Jianliang 의 총 보상 ($USD 128.93K ) Hong Kong 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 233.55K ).

보상과 수익: 회사가 수익성이 없는 동안 Jianliang 의 보상이 증가했습니다.


CEO

Jianliang Song (68 yo)

2.9yrs

테뉴어

CN¥933,000

보상

Mr. Jianliang Song serves as an Executive Director at Raily Aesthetic Medicine International Holdings Limited and serves as its Chief Executive Officer since December 28, 2021. Mr. Song is responsible for...


리더십 팀

이름위치테뉴어보상소유권
Haishu Fu
Executive Chairman of the Board6.8yrsCN¥852.00k53.1%
HK$ 34.6m
Jianliang Song
CEO & Executive Director2.9yrsCN¥933.00k데이터 없음
Chunxiu Zhang
Chief Financial Officerno dataCN¥433.00k데이터 없음
Ying Wang
Executive Director2.9yrsCN¥558.00k데이터 없음
Oi Fat Chan
Company Secretary4yrs데이터 없음데이터 없음

3.5yrs

평균 재임 기간

47yo

평균 연령

경험이 풍부한 관리: 2135 의 관리팀은 경험 ( 3.5 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Haishu Fu
Executive Chairman of the Board6.8yrsCN¥852.00k53.1%
HK$ 34.6m
Jianliang Song
CEO & Executive Directorno dataCN¥933.00k데이터 없음
Ying Wang
Executive Director2.9yrsCN¥558.00k데이터 없음
Dequan Cao
Independent Non-Executive Director3.9yrsCN¥162.00k데이터 없음
Xiaofen Yang
Independent Non-Executive Director3.9yrsCN¥162.00k데이터 없음
Teng Liu
Independent Non-Executive Director3.9yrsCN¥162.00k데이터 없음

3.9yrs

평균 재임 기간

48.5yo

평균 연령

경험이 풍부한 이사회: 2135 의 이사회경험(평균 재직 기간 3.9 년)으로 간주됩니다.